[HTML][HTML] Anticancer drug resistance: An update and perspective
R Nussinov, CJ Tsai, H Jang - Drug Resistance Updates, 2021 - Elsevier
Driver mutations promote initiation and progression of cancer. Pharmacological treatment
can inhibit the action of the mutant protein; however, drug resistance almost invariably …
can inhibit the action of the mutant protein; however, drug resistance almost invariably …
Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation
The primary physiological process of respiration produces carbon dioxide (CO 2) that reacts
with water molecules which subsequently liberates bicarbonate (HCO–3) and protons …
with water molecules which subsequently liberates bicarbonate (HCO–3) and protons …
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
Inherent or acquired resistance to sotorasib poses a substantialt challenge for NSCLC
treatment. Here, we demonstrate that acquired resistance to sotorasib in isogenic cells …
treatment. Here, we demonstrate that acquired resistance to sotorasib in isogenic cells …
3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation
Y Choi, H Lee, M Ann, M Song, J Rheey, J Jang - Biofabrication, 2023 - iopscience.iop.org
Despite encouraging progress in the development of in vitro cancer models, in vitro cancer
models that simultaneously recapitulate the complexity of the tumor microenvironment and …
models that simultaneously recapitulate the complexity of the tumor microenvironment and …
Landscape of epithelial–mesenchymal plasticity as an emergent property of coordinated teams in regulatory networks
Elucidating the design principles of regulatory networks driving cellular decision-making has
fundamental implications in mapping and eventually controlling cell-fate decisions. Despite …
fundamental implications in mapping and eventually controlling cell-fate decisions. Despite …
[HTML][HTML] Precision oncology provides opportunities for targeting KRAS-inhibitor resistance
Novel inhibitors targeting Kirsten rat sarcoma virus homolog (KRAS) KRAS G12C in various
cancers have shown good initial efficacy, but therapy-related drug resistance eventually …
cancers have shown good initial efficacy, but therapy-related drug resistance eventually …
[HTML][HTML] Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies
Purinergic signalling, consisting of extracellular purines and purinergic receptors, modulates
cell proliferation, invasion and immunological reaction during cancer progression. Here, we …
cell proliferation, invasion and immunological reaction during cancer progression. Here, we …
A systems biology approach for addressing cisplatin resistance in non-small cell lung cancer
S Ramisetty, P Kulkarni, S Bhattacharya… - Journal of Clinical …, 2023 - mdpi.com
Translational research in medicine, defined as the transfer of knowledge and discovery from
the basic sciences to the clinic, is typically achieved through interactions between members …
the basic sciences to the clinic, is typically achieved through interactions between members …
Cancer Immunoediting and beyond in 2021
EM Borroni, F Grizzi - International journal of molecular sciences, 2021 - mdpi.com
Human cancer has been depicted as a non-linear dynamic system that is discontinuous in
space and time, but progresses through different sequential states (Figure 1)[1, 2]. Cancer …
space and time, but progresses through different sequential states (Figure 1)[1, 2]. Cancer …
Leveraging deep learning algorithms for synthetic data generation to design and analyze biological networks
S Achuthan, R Chatterjee, S Kotnala, A Mohanty… - Journal of …, 2022 - Springer
The use of synthetic data is gaining an increasingly prominent role in data and machine
learning workflows to build better models and conduct analyses with greater statistical …
learning workflows to build better models and conduct analyses with greater statistical …